Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.77 Analyst target: $5.69 Upside: 640.21%
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.